Laser zaps NF1 skin bumps in new trial
NCT ID NCT06934928
First seen Mar 07, 2026 · Last updated May 11, 2026 · Updated 8 times
Summary
This study tests whether monthly alexandrite laser treatments can safely shrink skin tumors in people with Neurofibromatosis Type 1 (NF1). Ten adults will receive up to six laser sessions, with some areas cooled to improve comfort. Researchers will measure tumor size, appearance, and patient satisfaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 (NF1) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wellman Center for Photomedicine, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.